Author Question: Which of the following is NOT an area where subcutaneous injections may be given? a. Lower abdomen ... (Read 50 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
Which of the following is NOT an area where subcutaneous injections may be given?
 a. Lower abdomen
  b. Mid-back
  c. Lower leg
  d. Upper buttock
  e. Upper arm

Question 2

Incipient decay is ____________.
 a. arrested decay
  b. beginning decay
  c. decay that has reached the pulp
  d. none of the above



Ahernandez18

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

c

Answer to Question 2

b
RATIONALE: Incipient decay is beginning decay.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library